Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion type Assertion NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_head.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion description "[However, the ubiquity, extent, and correlation with disease progression suggest that aberrant DNA methylation is the dominant mechanism for TSG silencing and clonal variation in MDS evolution to AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_provenance.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion evidence source_evidence_literature NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_provenance.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion SIO_000772 18832655 NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_provenance.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion wasDerivedFrom befree-20140225 NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_provenance.
- NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_assertion wasGeneratedBy ECO_0000203 NP851931.RAaPfZWB9wy3ar8iggKe7VCeZDBZOv0bdu3IyY25Adnnw130_provenance.